Skip to main content

View full-text article in PMC

. 2019 Jun 18;7:e7025. doi: 10.7717/peerj.7025

Table 2. Association between the expression of circulating COL6A3, SERPINH1 and PLEKHG1 in gastric cancer and clinicopathologic characteristics.

Variable	*COL6A3*			*SERPINH1*			*PLEKHG1*
	n	Expression status	P	n	Expression status	P	n	Expression status	P
Age
<50	12	0.179 (0.028–1.250)	0.7091	12	0.190 (0.073–1.430)	0.0034^**	10	0.130 (0.003–1.052)	0.4517
≥50	43	0.147 (0.011–47.014)	0.7091	44	0.47 (0.374–116.407)	0.0034^**	31	0.148 (0.036–119.46)	0.4517
Sex
Male	42	0.150 (0.011–10.386)	0.5496	43	0.399 (0.374–8.283)	0.1856	30	0.126 (0.036–2.447)	0.9633
Female	13	0.162 (0.018–47.014)	0.5496	13	0.325 (0.038–116.41)	0.1856	11	0.161 (0.003–119.46)	0.9633
Stage
I + II + III	36	0.150 (0.011–47.014)	0.1616	37	0.374 (0.038–116.41)	0.4697	27	0.127 (0.003–119.46)	0.5101
IV	18	0.190 (0.018–10.386)	0.1616	18	0.454 (0.118–3.089)	0.4697	13	0.198 (0.065–1.214)	0.5101
Lymph node metastasis
<15	30	0.106 (0.229–47.014)	0.0233^*	31	0.374 (0.221–116.41)	0.6848	20	0.118 (0.036–119.46)	0.6207
≥15	7	0.225 (0.155–0.698)	0.0233^*	7	0.472 (0.039–3.623)	0.6848	7	0.116 (0.037–0.336)	0.6207
Differentiation
Poor	19	0.198 (0.011–47.01)	0.881	19	0.362 (0.127–116.41)	0.0231^*	12	0.110 (0.003–119.46)	0.1059
Moderately or well-differentiated	11	0.033 (0.018–0.693)	0.881	11	0.678 (0.159–3.089)	0.0231^*	10	0.106 (0.048–2.447)	0.1059

Notes.

^*

P value < 0.05.

^**

P value < 0.01.